Zhejiang Orient Gene Biotech Co., Ltd.
SSE:688298.SS
26.98 (CNY) • At close June 11, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| -568.822 | -418.269 | 2,097.431 | 4,940.646 | 1,680.331 | 77.508 | 63.956 | 32.706 | 35.627 |
| Depreciation & Amortization
| 206.378 | 165.489 | 86.56 | 37.306 | 7.439 | 6.383 | 5.481 | 4.592 | 4.506 |
| Deferred Income Tax
| 0 | -27.751 | -120.786 | -24.227 | -40.682 | -0.667 | -1.597 | 0.946 | -1.839 |
| Stock Based Compensation
| 0 | 0 | 120.786 | 24.227 | 40.682 | 0.667 | 0 | 0 | 0 |
| Change In Working Capital
| -141.46 | -1,573.426 | 101.818 | 113.54 | -12.464 | -36.216 | -29.957 | -13.331 | -36.555 |
| Accounts Receivables
| -109.369 | 210.278 | 825.398 | -692.053 | -640.46 | -31.931 | -14.391 | -9.885 | -22.286 |
| Inventory
| 1.912 | -86.228 | -775.131 | -98.703 | -379.081 | -4.443 | -28.414 | -5.959 | -15.563 |
| Accounts Payables
| 0 | -1,669.725 | 172.337 | 928.523 | 1,047.758 | 0.824 | 14.445 | 1.568 | 3.133 |
| Other Working Capital
| -34.003 | -27.751 | -120.786 | -24.227 | -40.682 | -0.667 | -1.543 | -7.372 | -20.992 |
| Other Non Cash Items
| 155.578 | 251.879 | 710.115 | 112.362 | 115.001 | 6.538 | 4.846 | 9.578 | 8.23 |
| Operating Cash Flow
| -348.327 | -1,602.078 | 2,995.924 | 5,203.854 | 1,790.307 | 54.212 | 44.326 | 33.545 | 11.809 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -924.095 | -996.047 | -1,051.936 | -507.872 | -126.933 | -11.901 | -18.878 | -13.384 | -4.652 |
| Acquisitions Net
| -320.76 | -77.709 | -184.873 | -43.705 | 127.021 | 0.169 | 4.769 | 6.883 | 0.01 |
| Purchases Of Investments
| -318.224 | -471.047 | -1,739.858 | -1,523.096 | -3,406 | 0 | 0 | 0 | -2.647 |
| Sales Maturities Of Investments
| 1,026.739 | 596.095 | 678.683 | 1,751.25 | 2,984.008 | 0 | 0 | 0 | 7.001 |
| Other Investing Activites
| -133.809 | -1,212.559 | -77.716 | 1.787 | -126.933 | 0 | 0.124 | -2.377 | 85.741 |
| Investing Cash Flow
| -670.15 | -2,161.267 | -2,375.7 | -321.637 | -548.836 | -11.732 | -18.754 | -15.761 | 85.453 |
| Financing Activities: | |||||||||
| Debt Repayment
| -130.95 | 440.182 | 43.788 | 0 | -26.961 | -23.039 | -6 | -20 | -21.65 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -16.631 | -351.14 | -742.036 | -504.672 | -25.287 | -33.217 | -3.677 | -3.917 | -6.711 |
| Other Financing Activities
| -304.156 | -39.506 | -0 | -4.502 | 555.542 | -4.036 | 3.956 | 5.695 | 0.004 |
| Financing Cash Flow
| -451.737 | 49.536 | -698.248 | -509.174 | 503.294 | -60.292 | -5.721 | -18.223 | -28.356 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| 51.886 | 85.852 | 536.645 | -75.44 | -29.777 | 0.925 | 4.557 | -2.465 | -0.102 |
| Net Change In Cash
| -1,418.328 | -3,627.957 | 458.622 | 4,297.603 | 1,714.988 | -16.886 | 24.409 | -2.904 | 68.803 |
| Cash At End Of Period
| 1,510.275 | 2,928.603 | 6,556.56 | 6,097.938 | 1,800.335 | 85.347 | 102.233 | 77.824 | 80.727 |